Tuning microbial hosts for membrane protein production.

Institute of Molecular Biotechnology, Graz University of Technology, Petersgasse 14, 8010 Graz, Austria.
Microbial Cell Factories (Impact Factor: 4.25). 01/2009; 8:69. DOI: 10.1186/1475-2859-8-69
Source: PubMed

ABSTRACT The last four years have brought exciting progress in membrane protein research. Finally those many efforts that have been put into expression of eukaryotic membrane proteins are coming to fruition and enable to solve an ever-growing number of high resolution structures. In the past, many skilful optimization steps were required to achieve sufficient expression of functional membrane proteins. Optimization was performed individually for every membrane protein, but provided insight about commonly encountered bottlenecks and, more importantly, general guidelines how to alleviate cellular limitations during microbial membrane protein expression. Lately, system-wide analyses are emerging as powerful means to decipher cellular bottlenecks during heterologous protein production and their use in microbial membrane protein expression has grown in popularity during the past months.This review covers the most prominent solutions and pitfalls in expression of eukaryotic membrane proteins using microbial hosts (prokaryotes, yeasts), highlights skilful applications of our basic understanding to improve membrane protein production. Omics technologies provide new concepts to engineer microbial hosts for membrane protein production.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fatty acid ethyl esters are secondary metabolites that are produced during microbial fermentation, in fruiting plants, and in higher organisms during ethanol stress. In particular, volatile medium-chain fatty esters are important flavor compounds that impart desirable fruit aromas to fermented beverages including beer and wine. The biochemical synthesis of medium-chain fatty acid ethyl esters is poorly understood but likely involves acyl-CoA:ethanol O-acyltransferases. Here, we characterize the enzyme ethanol hexanoyl transferase 1 (Eht1) from the brewer's yeast Saccharomyces cerevisiae. Full-length Eht1 was successfully overexpressed from a recombinant yeast plasmid and purified on the milligram scale after detergent solubilization of sedimenting membranes. Recombinant Eht1 was functional as an acyltransferase and, unexpectedly, was optimally active toward octanoyl-CoA with kcat =0.28 ± 0.02 s−1 and KM =1.9 ± 0.6 μM. Eht1 was also revealed to be active as a thioesterase, but was not able to hydrolyse p-nitrophenyl acyl esters in contrast to the findings of a previous study. Low-resolution structural data and site-directed mutagenesis provide experimental support for a predicted α/β-hydrolase domain featuring a Ser-Asp-His catalytic triad. The S. cerevisiae gene YBR177C/EHT1 should thus be reannotated as coding for an octanoyl-CoA:ethanol acyltransferase that can also function as a thioesterase. This article is protected by copyright. All rights reserved.
    Yeast 10/2014; DOI:10.1002/yea.3046 · 1.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cytochrome P450 1B1 (CYP1B1) is a universal cancer marker and is implicated in many other disorders. Mutations in CYP1B1 are also associated with childhood blindness due to primary congenital glaucoma (PCG). To understand the CYP1B1 mediated etiopathology of PCG and pathomechanism of various cancers, it is important to carry out its functional studies. Heterologous expression of CYP1B1 in prokaryotes is imperative because bacteria yield a higher amount of heterologous proteins in lesser time and so the expressed protein is ideal for functional studies. In such expression system there is no interference by other eukaryotic proteins. But the story is not that simple as expression of heterologous CYP1B1 poses many technical difficulties. Investigators have employed various modifications/deletions of CYP N-terminus to improve CYP1B1 expression. However, the drawback of these studies is that it changes the original protein and, as a result, invalidates functional studies. The present study examines the role of various conditions and reagents in successful and consistent expression of sufficient quantities of unmodified/native human CYP1B1 in E. coli. We aimed at expressing CYP1B1 in various strains of E. coli and in the course developed a protocol that results in high expression of unmodified protein sufficient for functional/biophysical studies. We examined CYP1B1 expression with respect to different expression vectors, bacterial strains, types of culture media, time, Isopropyl β-D-1-thiogalactopyranoside concentrations, temperatures, rotations per minute, conditioning reagents and the efficacy of a newly described technique called double colony selection. We report a protocol that is simple, easy and can be carried out in any laboratory without the requirement of a fermentor. Though employed for CYP1B1 expression, this protocol can ideally be used to express any eukaryotic membrane protein.
    PLoS ONE 10/2014; 9(10):e110473. DOI:10.1371/journal.pone.0110473 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Human C-C chemokine receptor 3 (CCR3), belonging to the G protein-coupled receptor (GPCR) family, plays a central role in various allergic diseases. Although good understanding on this protein is of critical importance to drug design, studies on the structure and functions of CCR3 are still limited, mainly due to the difficulties to obtain a large quantity of pure and functional protein. Here we report high-level production of human CCR3 fused to maltose binding protein (MBP) in Escherichia coli. Over-expression of MBP-CCR3 was achieved by systematically optimizing expression conditions, and Fos choline-14 was found to be an optimum surfactant for solubilization and stabilization of MBP-CCR3 in purification. After the two-step chromatography purification, the yield of MBP-CCR3 was 2–4 mg/l culture. The binding activity of purified MBP-CCR3 was verified by binding with its endogenous ligands CCL11 and CCL24, with KD of 2.90 × 10−6 and 1.81 × 10−6 M, respectively. This is the first report for that MBP fused recombinant CCR3 (MBP-CCR3) produced in E. coli still maintains its binding activity with its endogenous ligands, which provides an efficient way to produce functional GPCR proteins at large scale for further structural and functional studies.
    PROCESS BIOCHEMISTRY 12/2014; 50(2). DOI:10.1016/j.procbio.2014.12.001 · 2.52 Impact Factor

Full-text (2 Sources)

Available from
May 28, 2014